Radiation Toxicity: Clinical Trials

38 trials for Radiation Toxicity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

24 completed, 6 unknown, 4 terminated, 2 recruiting. 38 Phase 2, 10 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 238Completed 24, Unknown 6, Terminated 4, Recruiting 2, Active not recruiting 1, Enrolling by invitation 1
Phase 110Completed 5, Unknown 3, Active not recruiting 1, Recruiting 1
Phase 31Completed 1

Follow Radiation Toxicity: new trials by email Literature Review of Radiation Toxicity trials Research Report on Radiation Toxicity

Trials (filtered) newest first · largest first

All 38 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor
Proton radiotherapy, combined platinum based chemotherapy - Thymus Epithelial Tumor, Proton Radiotherapy
Phase 2RecruitingJian Chen552024-05-062025-06-13
The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
Short Chain Fatty Acid, Tapioca Flour - Toxicity, Radiation Toxicity
Phase 1 / Phase 2RecruitingUNC Lineberger Comprehensive Cancer Center1222023-12-152026-10-05
Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT)
stereotactic body radiotherapy, 20 Gy in 1 fraction - Ventricular Tachycardia, Arrhythmia
Phase 2Enrolling by invitationMcGill University Health Centre/Research Institute of the McGill University Health Centre92023-07-012025-03-18
Deep-sea Fish Oil for Prevention of Acute Radiation-induced Esophagitis
Deep-sea fish oil, Placebo - Radiation Toxicity, Esophagitis
Phase 2UnknownFirst Affiliated Hospital of Chengdu Medical College1202023-01-152024-05-01
Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer
External beam radiation therapy, High-dose-rate brachytherapy, Goserelin 10.8 mg - Prostate Adenocarcinoma, Radiation Toxicity
Phase 1 / Phase 2Active not recruitingGerman Oncology Center, Cyprus402021-08-012026-09-17
Efficacy of the Mepitel® Film on the Prevention of Radiodermatitis in the Inguinal Fold.
Mepitel® film, Flamigel® - Radiodermatitis, Radiation Toxicity
Phase 1 / Phase 2UnknownJules Bordet Institute352021-01-012020-11-05
Mesenchymal Stem Cells for Radiation-induced Xerostomia
Autologous adipose-derived mesenchymal stem/stromal cells, Placebo - Radiation Toxicity, Xerostomia Due to Radiotherapy
Phase 1 / Phase 2UnknownCopenhagen University Hospital, Rigshospitalet302020-08-012020-10-22
Feasibility of Combined Focused Ultrasound and Radiotherapy Treatment in Patients With Painful Bone Metastasis
combined radiotherapy and MR-HIFU - Bone Metastases, Bone Neoplasm
Phase 1 / Phase 2CompletedUMC Utrecht102019-04-112024-02-07
Photobiomodulation for Breast Cancer Radiodermatitis
Photobiomodulation - Breast Cancer, Radiodermatitis
Phase 2 / Phase 3CompletedAC Camargo Cancer Center482018-09-262021-08-13
Re-irradiation for Pelvic Recurrences in Rectal Cancer Patients
Hyperfractionated external beam radiation - Rectal Cancer, Recurrence
Phase 2CompletedAarhus University Hospital162015-01-012023-04-18
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Rituximab, Cytarabine, Methotrexate - Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects
Phase 2CompletedRadiation Therapy Oncology Group912011-09-012023-07-20
Radiation Therapy in Treating Patients With Prostate Cancer
36.25 Gy IMRT, 51.6 Gy IMRT - Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment
Phase 2CompletedRadiation Therapy Oncology Group2552011-09-012022-06-09
L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors
Placebo, Oral L-Arginine - Male Erectile Disorder, Prostate Cancer
Phase 2CompletedWake Forest University Health Sciences1402010-10-012021-09-28
Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy
alkaline water, distilled water, external beam radiation therapy (EBRT) - Radiation Toxicity, Recurrent Breast Cancer
Phase 2CompletedCase Comprehensive Cancer Center452010-05-012015-06-18
Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06
45 Gy/25 fractions - Endometrial Cancer, Gastrointestinal Complications
Phase 2TerminatedCancer Trials Ireland922010-03-012026-04-13
Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy
selenomethionine, placebo, cisplatin - Chemotherapeutic Agent Toxicity, Mucositis
Phase 2TerminatedRoswell Park Cancer Institute182009-06-012014-08-22
Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer
lovastatin, questionnaire administration, adjuvant therapy - Breast Cancer, Radiation Toxicity
Phase 2TerminatedVirginia Commonwealth University32009-04-012013-06-20
Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg
Chemotherapy, Radiation therapy, Surgery - Lymphedema, Musculoskeletal Complications
Phase 2CompletedRadiation Therapy Oncology Group982008-03-012019-06-12
Spinal Cord Compression Re-Treat Study
Cumulative BED ≤ 100, Cumulative BED ≤ 130 Gy2 - Pain, Radiation Toxicity
Phase 2CompletedCancer Trials Ireland222007-10-012019-07-29
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer
bevacizumab, placebo, magnetic resonance imaging - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma
Phase 2CompletedNational Cancer Institute (NCI)112007-06-012014-05-09

Showing 20 of 38. Sign in to see all of them.

Narrower conditions

Radiation Injuries (38)  ·  Head and Neck Neoplasms (8)  ·  Drug-Related Side Effects and Adverse Reactions (7)  ·  Squamous Cell Carcinoma of Head and Neck (7)  ·  Breast Neoplasms (4)  ·  Prostatic Neoplasms (4)  ·  Xerostomia (4)  ·  Brain Neoplasms (3)  ·  Lung Neoplasms (3)  ·  Lymphoma (3)  ·  Astrocytoma (2)  ·  Choroid Plexus Neoplasms (2)  ·  Ependymoma (2)  ·  Glioma (2)  ·  Laryngeal Neoplasms (2)

Broader conditions

Wounds and Injuries (38)  ·  Neoplasms (31)  ·  Neoplasms by Site (29)  ·  Neoplasms by Histologic Type (13)  ·  Neoplasms, Glandular and Epithelial (9)  ·  Carcinoma (8)  ·  Chemically-Induced Disorders (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Carcinoma, Squamous Cell (7)  ·  Pathologic Processes (7)  ·  Stomatognathic Diseases (7)  ·  Genital Diseases (6)  ·  Mouth Diseases (6)  ·  Salivary Gland Diseases (6)  ·  Urogenital Diseases (6)

Interventions

Radiotherapy (13)  ·  Amifostine (9)  ·  Cisplatin (9)  ·  Etoposide (4)  ·  Paclitaxel (4)  ·  Carboplatin (2)  ·  Filgrastim (2)  ·  Radiation (2)  ·  Androgen Antagonists (1)  ·  ArginMax (1)  ·  Arginine (1)  ·  Bevacizumab (1)  ·  Brachytherapy (1)  ·  Butyric Acid (1)  ·  Chemotherapy, Adjuvant (1)

Sponsors

Radiation Therapy Oncology Group (8)  ·  Cancer Trials Ireland (2)  ·  National Cancer Institute (NCI) (2)  ·  Wake Forest University Health Sciences (2)  ·  AC Camargo Cancer Center (1)  ·  Aarhus University Hospital (1)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Case Comprehensive Cancer Center (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Dana-Farber Cancer Institute (1)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  First Affiliated Hospital of Chengdu Medical College (1)  ·  German Oncology Center, Cyprus (1)  ·  Jian Chen (1)  ·  Jonsson Comprehensive Cancer Center (1)

Countries

United States (23)  ·  Canada (6)  ·  China (2)  ·  Denmark (2)  ·  Ireland (2)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Cyprus (1)  ·  France (1)  ·  Hungary (1)  ·  Israel (1)  ·  Italy (1)  ·  Netherlands (1)  ·  New Zealand (1)

Top investigators

Scott Okuno, MD (2)  ·  Antonio Omuro, MD (1)  ·  Anurag Singh (1)  ·  Avraham Eisbruch, MD (1)  ·  Burton L. Eisenberg, MD (1)  ·  Charles Gillham, Dr (1)  ·  Charles Kunos, MD (1)  ·  Charlotte Lynggaard, MD (1)  ·  Christos E. Emmanouilides, MD (1)  ·  David G. Kirsch, MD, PhD (1)  ·  Dean L. McCarley, MD (1)  ·  Dian Wang, MD, PhD (1)  ·  Edward G. Shaw, MD (1)  ·  Fred R. Rosen, MD (1)

Results publications

PMID 16549835, PMID 16823067, PMID 17336213, PMID 17398031, PMID 17418968, PMID 19540060, PMID 19564532, PMID 19634161, PMID 20441239, PMID 21892091, PMID 22541957, PMID 24619017, PMID 25667281, PMID 36482188, PMID 36925074, PMID 36995690

NIH funding

U10CA081851 (2), 2014 (1), N01CM62202 (1), P30CA006516 (1), P30CA016672 (1), P30CA023074 (1)